Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KARIM ARNAOUT

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1265697213
CMS profile
148674
Location
SALISBURY, MD

General Payments · PY2018–2024

$4,062.62

  • Reported across 103 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,912.45

33 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $555.32 26
Consulting Fee $525.00 1
Long term medical supply or device loan $482.13 5
Grant $350.00 1

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $665.12 16
PY2019 $462.88 15
PY2020 $56.43 3
PY2021 $117.87 6
PY2022 $165.81 7
PY2023 $682.06 23
PY2024 $1,912.45 33

Payment records · PY2024 (33)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $13.60 03/25/2024 Food and Beverage Undisputed 01/23/2026 1103240465 CMS
ABBVIE INC. $23.32 05/14/2024 Food and Beverage Undisputed 01/23/2026 1103240467 CMS
Adaptive Biotechnologies Corporation $21.40 05/13/2024 Food and Beverage Undisputed 01/23/2026 1150260910 CMS
Astellas Pharma US Inc $26.36 09/24/2024 Food and Beverage Undisputed 01/23/2026 1139398957 CMS
AstraZeneca Pharmaceuticals LP $350.00 02/13/2024 Grant Undisputed 01/23/2026 1104475000 CMS
AstraZeneca Pharmaceuticals LP $525.00 03/06/2024 Consulting Fee Undisputed 01/23/2026 1104339246 CMS
AstraZeneca Pharmaceuticals LP $26.41 05/01/2024 Food and Beverage Undisputed 01/23/2026 1104490678 CMS
AstraZeneca Pharmaceuticals LP $24.15 06/18/2024 Food and Beverage Undisputed 01/23/2026 1104416267 CMS
AstraZeneca Pharmaceuticals LP $29.42 11/16/2024 Food and Beverage Undisputed 01/23/2026 1105798648 CMS
Daiichi Sankyo Inc. $16.30 05/20/2024 Food and Beverage Undisputed 01/23/2026 1089394500 CMS
Daiichi Sankyo Inc. $17.70 09/05/2024 Food and Beverage Undisputed 01/23/2026 1089394502 CMS
E.R. Squibb & Sons, L.L.C. $31.98 03/20/2024 Food and Beverage Undisputed 01/23/2026 1101637079 CMS
Genentech USA, Inc. $22.11 01/24/2024 Food and Beverage Undisputed 01/23/2026 1133044566 CMS
Gilead Sciences, Inc. $20.41 06/14/2024 Food and Beverage Undisputed 01/23/2026 1133797315 CMS
Janssen Pharmaceuticals, Inc $15.43 04/18/2024 Food and Beverage Undisputed 01/23/2026 1078046546 CMS
Novartis Pharmaceuticals Corporation $99.70 01/18/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086728505 CMS
Novartis Pharmaceuticals Corporation $12.42 02/12/2024 Food and Beverage Undisputed 01/23/2026 1086728487 CMS
Novartis Pharmaceuticals Corporation $99.70 02/16/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086728507 CMS
Novartis Pharmaceuticals Corporation $99.70 03/15/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086728509 CMS
Novartis Pharmaceuticals Corporation $19.92 03/22/2024 Food and Beverage Undisputed 01/23/2026 1086728493 CMS
Novartis Pharmaceuticals Corporation $99.70 04/18/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086728511 CMS
Novartis Pharmaceuticals Corporation $11.36 05/14/2024 Food and Beverage Undisputed 01/23/2026 1086728495 CMS
Novartis Pharmaceuticals Corporation $83.33 05/16/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086728513 CMS
Novartis Pharmaceuticals Corporation $21.37 05/23/2024 Food and Beverage Undisputed 01/23/2026 1086728497 CMS
Novartis Pharmaceuticals Corporation $30.87 06/10/2024 Food and Beverage Undisputed 01/23/2026 1086728499 CMS
Novartis Pharmaceuticals Corporation $11.92 06/21/2024 Food and Beverage Undisputed 01/23/2026 1086728501 CMS
Novartis Pharmaceuticals Corporation $21.50 07/17/2024 Food and Beverage Undisputed 01/23/2026 1086728503 CMS
Novartis Pharmaceuticals Corporation $27.36 10/18/2024 Food and Beverage Undisputed 01/23/2026 1086728517 CMS
PFIZER INC. $20.41 05/25/2024 Food and Beverage Undisputed 01/23/2026 1131321440 CMS
PUMA BIOTECHNOLOGY, INC. $17.75 10/22/2024 Food and Beverage Undisputed 01/23/2026 1113862057 CMS
Tempus AI, Inc $18.93 09/17/2024 Food and Beverage Undisputed 01/23/2026 1150160506 CMS
Tempus AI, Inc $26.63 10/23/2024 Food and Beverage Undisputed 01/23/2026 1150160508 CMS
Tempus AI, Inc $26.29 10/31/2024 Food and Beverage Undisputed 01/23/2026 1150160510 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.